ANGX three-lens brief
Evidence-based stock research on ANGX. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Price up 14.97% in the last session — a material single-day move. · Currently unprofitable on a trailing basis — no P/E multiple available.
- Price up 14.97% in the last session — a material single-day move.
- 50-day MA above 200-day MA (golden-cross regime); price above both.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $8.20 — 91% above current (5 analysts).
- Reported earnings on 2026-11-10.
ANGX closed at $4.30 (+14.97%) as of 2026-11-12. Market cap: $803.05M. Price is above the 50-day MA and above the 200-day MA. Positives: price up 14.97% in the last session — a material single-day move.; 50-day MA above 200-day MA (golden-cross regime); price above both.. Concerns: currently unprofitable on a trailing basis — no P/E multiple available.. Last quarter: Revenue $159.02M, net income -$5.15M, free cash flow $8.14M.
Why three lenses on ANGX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ANGX across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/ANGX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ANGX brief"></iframe>